AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.77 and traded as high as $5.90. AIkido Pharma shares last traded at $5.63, with a volume of 280,517 shares trading hands.
AIkido Pharma Stock Down 5.2%
The stock has a market capitalization of $30.88 million, a price-to-earnings ratio of -1.45 and a beta of 0.93. The stock has a fifty day moving average of $4.64 and a 200-day moving average of $3.77.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Stories
- Five stocks we like better than AIkido Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Top 5 Stocks Hedge Funds Are Buying Right Now
- The Significance of Brokerage Rankings in Stock Selection
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- What is a Death Cross in Stocks?
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
